Johnson & Johnson’s decline mirrors broader healthcare sector weakness, halting a six-session rally in Tuesday trading.
Johnson & Johnson (JNJ) shares fell 1.76% to close at $253.97 on Tuesday, breaking a six-day streak of gains. The drop aligned with a broader downturn in the healthcare sector, which saw losses across multiple stocks.
Prior to the decline, JNJ had posted consistent gains, reflecting investor confidence in the sector. Competitors like Merck (MRK) and AbbVie also faced downward pressure during the session.
The move did not trigger significant market reactions beyond the sector, with trading volumes remaining in line with recent averages.